Loading...

NUWE NUWELLIS INC Earnings Reports 8-K Filing

NWLL

NW

NUWELLIS INC

(NUWE)

2024 8-K

Show Summary

Show Summary

Equity Offerings

Reverse Stock Split

Financial Statements

Corporate Presentation

Financial Results

Nasdaq Compliance

Financial Results

Warrant Inducement

Financial Results

Settlement Agreement

Agreement Termination

Financial Results

Nasdaq Compliance

Agreement for Registered Di...

Amendment and Risk Factor U...

Corporate Presentation and ...

Termination of Agreement

Reverse Stock Split

Delisting Notice

Amendment to Supply Agreement

Earnings Report

Public Offering

Financial Results

Corporate Presentation

Financial Results Announcement

Appointment and Resignation

Placement Agency Agreement ...

FDA Approval for Selective ...

Appointment of CFO

Resignation of CFO and Appo...

Financial Results

Supply and Collaboration Ag...

Appointment of Michael McCo...

Annual Meeting Results

Financial Results

Presentation at Oppenheimer...

Financial Results and Induc...

Management Changes

Financial Results

Meeting Adjournment and Vot...

External Links:

Nuwellis, Inc. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 with the SEC. The report provides an overview of the company's business, including its focus on developing, manufacturing, and commercializing medical dev

AI Assistant

NUWELLIS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.